ES2052534T3 - Nuevos anticuerpos monoclonales contra ifn-omega, procedimiento para su preparacion y su empleo para la purificacion asi como para la deteccion de ifn-omega. - Google Patents

Nuevos anticuerpos monoclonales contra ifn-omega, procedimiento para su preparacion y su empleo para la purificacion asi como para la deteccion de ifn-omega.

Info

Publication number
ES2052534T3
ES2052534T3 ES87113896T ES87113896T ES2052534T3 ES 2052534 T3 ES2052534 T3 ES 2052534T3 ES 87113896 T ES87113896 T ES 87113896T ES 87113896 T ES87113896 T ES 87113896T ES 2052534 T3 ES2052534 T3 ES 2052534T3
Authority
ES
Spain
Prior art keywords
omega
ifn
purification
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87113896T
Other languages
English (en)
Inventor
Guenther Adolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2052534T3 publication Critical patent/ES2052534T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS ANTICUERPOS MONOCLONALES, QUE REACCIONAN ESPECIFICAMENTE CON INTERFERON HUMANO DE TIPO OMEGA-IFN Y SIN EMBARGO NO LO HACEN CON OTROS INTERFERONES HUMANOS, AL PROCEDIMIENTO PARA SU PREPARACION ASI COMO SU APLICACION A LA PURIFICACION Y DETECCION DE IFN-OMEGA.
ES87113896T 1986-10-01 1987-09-23 Nuevos anticuerpos monoclonales contra ifn-omega, procedimiento para su preparacion y su empleo para la purificacion asi como para la deteccion de ifn-omega. Expired - Lifetime ES2052534T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863633323 DE3633323A1 (de) 1986-10-01 1986-10-01 Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega

Publications (1)

Publication Number Publication Date
ES2052534T3 true ES2052534T3 (es) 1994-07-16

Family

ID=6310754

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87113896T Expired - Lifetime ES2052534T3 (es) 1986-10-01 1987-09-23 Nuevos anticuerpos monoclonales contra ifn-omega, procedimiento para su preparacion y su empleo para la purificacion asi como para la deteccion de ifn-omega.

Country Status (22)

Country Link
US (1) US5317089A (es)
EP (1) EP0262571B1 (es)
JP (1) JP2622260B2 (es)
KR (1) KR960009724B1 (es)
AT (1) ATE83262T1 (es)
AU (1) AU616158B2 (es)
CA (1) CA1320160C (es)
DD (1) DD269165A5 (es)
DE (2) DE3633323A1 (es)
DK (1) DK172801B1 (es)
ES (1) ES2052534T3 (es)
FI (1) FI92716C (es)
GR (1) GR3006846T3 (es)
HU (1) HUT45092A (es)
IE (1) IE59836B1 (es)
IL (1) IL84040A (es)
NO (1) NO173831C (es)
NZ (1) NZ222006A (es)
PH (1) PH30662A (es)
PT (1) PT85830B (es)
SU (1) SU1602393A3 (es)
ZA (1) ZA877354B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0310940B1 (en) * 1987-09-30 1994-11-23 Fujirebio Kabushiki Kaisha Analytical element for enzyme immunoassays
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
AU2004236174B2 (en) 2001-10-10 2011-06-02 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
CN103173282A (zh) * 2004-06-16 2013-06-26 帝斯曼知识产权资产管理有限公司 对叶绿素进行酶促脱色的组合物和方法
EP2536435B1 (en) * 2010-02-18 2017-11-15 Janssen Biotech, Inc. Monkey homolog of human interferon omega
EP2970461A4 (en) 2013-03-15 2016-11-23 Janssen Biotech Inc INTERFERON ALPHA AND OMEGA ANTIBODY ANTAGONISTS
TWI713453B (zh) * 2014-06-23 2020-12-21 美商健生生物科技公司 干擾素α及ω抗體拮抗劑

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
DE3306060A1 (de) * 1983-02-22 1984-08-23 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung
DE3584198D1 (de) * 1984-08-01 1991-10-31 Boehringer Ingelheim Int Neue genetische sequenzen, die durch sie codierten interferon-peptide vom typ i und diese sie produzierende organismen.
DE3574145D1 (en) * 1984-08-27 1989-12-14 Genentech Inc Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IE872625L (en) 1988-04-01
AU7921787A (en) 1988-04-21
DD269165A5 (de) 1989-06-21
FI874273A (fi) 1988-04-02
IL84040A (en) 1992-02-16
DK513687A (da) 1988-04-02
NO874107D0 (no) 1987-09-30
GR3006846T3 (es) 1993-06-30
IE59836B1 (en) 1994-04-06
NO173831B (no) 1993-11-01
EP0262571A2 (de) 1988-04-06
PT85830A (de) 1987-10-01
JPS63105673A (ja) 1988-05-10
NZ222006A (en) 1990-08-28
ATE83262T1 (de) 1992-12-15
ZA877354B (en) 1989-06-28
DE3783002D1 (de) 1993-01-21
NO173831C (no) 1994-02-09
DK513687D0 (da) 1987-09-30
FI92716B (fi) 1994-09-15
KR880005258A (ko) 1988-06-28
US5317089A (en) 1994-05-31
EP0262571A3 (en) 1989-05-31
KR960009724B1 (en) 1996-07-23
HUT45092A (en) 1988-05-30
PH30662A (en) 1997-09-16
EP0262571B1 (de) 1992-12-09
FI92716C (fi) 1994-12-27
IL84040A0 (en) 1988-02-29
DE3633323A1 (de) 1988-04-07
CA1320160C (en) 1993-07-13
AU616158B2 (en) 1991-10-24
SU1602393A3 (ru) 1990-10-23
NO874107L (no) 1988-04-05
FI874273A0 (fi) 1987-09-30
PT85830B (pt) 1990-07-31
DK172801B1 (da) 1999-07-26
JP2622260B2 (ja) 1997-06-18

Similar Documents

Publication Publication Date Title
ES2022365B3 (es) Material compuesto ligero de peso.
ES520261A0 (es) Procedimiento para la preparacion de dipeptidos carboxialquilicos.
EP0219076A3 (en) Sustained release composition
AT389445B (de) Orale zubereitung, insbesondere zur bekaempfung von mundgeruch
ES507761A0 (es) Procedimiento para la preparacion de nuevas pirimidinonas .
ES521774A0 (es) Compuerta de gas mejorada para reducir sustancialmente la retrocirculacion de los gases.
ES519944A0 (es) Procedimiento para la preparacion de proteinas succiniladas que contienen hierro.
ES2052534T3 (es) Nuevos anticuerpos monoclonales contra ifn-omega, procedimiento para su preparacion y su empleo para la purificacion asi como para la deteccion de ifn-omega.
MX156652A (es) Procedimiento para la preparacion de novolacas de naftol oxitalcohiladas,modificadas,anionicas,tensoactivas
ES510730A0 (es) "procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo".
ES513808A0 (es) "procedimiento para la preparacion de tiazolo(3,2-a)pirimidinas sustituidas".
DK49783A (da) Fremgangsmaade til fremstilling af panthenolderivater
DK273983A (da) Stempelmotor med opslidset stempelring
IT8621229A0 (it) Procedimento per la preparazione di nitrato di potassio.
ES521088A0 (es) Procedimiento para la preparacion de pirroles triciclicos.
ES507180A0 (es) Procedimiento de preparacion de amino alcosi furanos o tio- fenos.
ES523060A0 (es) Procedimiento para la purificacion de n-metilpirrolidona.
ES516299A0 (es) "procedimiento para preparar nuevos derivados de 20,21-dinoreburnamenina".
ES522166A0 (es) Procedimiento para la obtencion de sulfonil- y sulfonil-azacicloheptan-2-onas.
EP0266563A3 (en) Use of 1-benzyl-amino-alkyl-pyrrolidinones as antidepressants
ES261957Y (es) Anillo roscado para fijar componentes dotados de rosca.
FI961105A0 (fi) Difluoristatoniviruksen vastaisia analogeja
IT8223733A0 (it) Preparazione e composizione derivato terapeutica che lo contiene. dell'isopropilamino-pirimidina, sua
ES513481A0 (es) "procedimiento de preparacion de 2,4-diamino-5-(3',4',5'-trimetoxibencil) pirimidina".
DK300083D0 (da) Fremgangsmade til fremstilling af et nonapeptid med immunstimulerende virkning

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 262571

Country of ref document: ES